Pharmacists are increasingly becoming one of the most valuable members of the healthcare team, particularly within specialist outpatient services. A recent study from Vanderbilt University Health System highlights just how significant their contribution can be, not only in improving patient care, but also in reducing costs for healthcare providers and insurers.
Published in the American Journal of Health-System Pharmacy, the research explored the impact of pharmacist interventions within a non-multiple sclerosis (MS) neurology clinic. The findings demonstrate that embedded neurology pharmacists can play a major role in improving treatment outcomes, increasing access to medication, and generating substantial financial savings.
The study reviewed patients who received at least one pharmacist intervention between January and March 2023. Over the course of just three months, pharmacists carried out an impressive 2,244 interventions across 741 patients. This equates to roughly three interventions per patient, highlighting the extensive level of support pharmacists provide within specialist neurology services.
The majority of interventions focused on coordination of care, accounting for 72% of all activities. These included helping patients navigate treatment pathways, liaising with providers, and ensuring medication access. General interventions made up 16%, while safety-related interventions represented 10%. Pharmacists also contributed to improving treatment efficacy and medication adherence, though these categories formed a smaller proportion of the overall activity.
Importantly, the study found that these interventions were highly efficient. Pharmacists spent a median of just 10 minutes per intervention, suggesting that impactful clinical support can be delivered without placing excessive strain on resources or workflow.
One of the most valuable aspects of the pharmacists’ work involved clinical recommendations. The pharmacists made 392 recommendations during the study period, of which 386 were accepted by healthcare providers, an exceptionally high acceptance rate that reflects the trust placed in pharmacist expertise.
The recommendations covered a wide range of patient needs. The most common involved changes to specialty medications, accounting for 34% of recommendations. Financial assistance referrals were also a key focus, making up 17% of interventions. Pharmacists additionally supported patient counselling, medication access, provider referrals, and safety monitoring.
Beyond the clinical benefits, the financial impact was striking. Through just 41 interventions involving medication discontinuations and dose adjustments, pharmacists achieved direct cost avoidance of more than $172,000 during the three-month study period. These savings underline the growing recognition that pharmacists are not simply supporting patient care, they are also helping healthcare systems operate more efficiently and sustainably.
The study reinforces the value of integrating pharmacists directly into outpatient neurology clinics, particularly within specialist pharmacy settings. Their ability to identify medication-related issues, optimise therapy, and improve access to treatment delivers measurable benefits for patients and providers alike.
As healthcare systems continue to face mounting financial pressures and increasing patient complexity, the role of specialist pharmacists is likely to become even more important. Studies such as this provide compelling evidence that pharmacist-led interventions are not merely an added benefit, they are an essential component of high-quality, cost-effective neurological care.